B
BioNote Inc
KRX:377740
BioNote Inc
KRX:377740
Price:
6 050
KRW
3.42%
Market Closed
Market Cap:
₩617.5B
Cash Flow Statement
Cash Flow Statement
BioNote Inc
BioNote Inc
Currency: KRW
| Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
464 663
|
307 798
|
285 041
|
(68 973)
|
(155 974)
|
(20 497)
|
19 173
|
81 651
|
40 355
|
55 261
|
42 377
|
120 155
|
117 649
|
|
| Depreciation & Amortization |
5 897
|
6 451
|
8 394
|
7 695
|
7 940
|
8 206
|
8 292
|
8 104
|
8 182
|
8 186
|
8 283
|
8 509
|
8 845
|
|
| Stock-Based Compensation |
1 980
|
1 637
|
0
|
0
|
0
|
0
|
7
|
40
|
70
|
100
|
123
|
120
|
120
|
|
| Other Non-Cash Items |
(74 951)
|
8 799
|
31 744
|
96 998
|
156 844
|
25 284
|
(12 320)
|
(72 211)
|
(30 965)
|
(30 003)
|
(18 138)
|
(97 581)
|
(101 840)
|
|
| Cash Taxes Paid |
158 684
|
157 006
|
171 106
|
95 845
|
69 140
|
40 454
|
27 941
|
6 818
|
5 933
|
5 003
|
9 881
|
17 114
|
15 871
|
|
| Cash Interest Paid |
82
|
84
|
84
|
86
|
544
|
603
|
664
|
676
|
254
|
234
|
259
|
282
|
300
|
|
| Change in Working Capital |
(139 184)
|
(73 948)
|
(90 525)
|
9 755
|
8 280
|
(17 187)
|
6 483
|
33 006
|
23 350
|
24 472
|
14 992
|
5 217
|
6 952
|
|
| Cash from Operating Activities |
256 425
N/A
|
249 100
-3%
|
234 653
-6%
|
45 475
-81%
|
17 090
-62%
|
(4 194)
N/A
|
21 628
N/A
|
50 550
+134%
|
40 922
-19%
|
57 917
+42%
|
47 513
-18%
|
36 301
-24%
|
31 606
-13%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(16 702)
|
(42 484)
|
(44 165)
|
(33 860)
|
(30 753)
|
(4 542)
|
(3 523)
|
(7 686)
|
(8 487)
|
(10 482)
|
(13 254)
|
(11 328)
|
(11 047)
|
|
| Other Items |
(164 642)
|
11 953
|
(584 684)
|
(557 762)
|
(449 573)
|
(477 013)
|
314 325
|
197 970
|
213 922
|
(71 688)
|
(278 103)
|
(162 985)
|
(213 056)
|
|
| Cash from Investing Activities |
(181 344)
N/A
|
(30 530)
+83%
|
(628 848)
-1 960%
|
(591 622)
+6%
|
(480 325)
+19%
|
(481 555)
0%
|
310 802
N/A
|
190 283
-39%
|
205 435
+8%
|
(82 170)
N/A
|
(291 357)
-255%
|
(174 314)
+40%
|
(224 103)
-29%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
0
|
73 280
|
0
|
73 749
|
74 124
|
844
|
0
|
0
|
(1 507)
|
(3 108)
|
(3 117)
|
(3 117)
|
(3 935)
|
|
| Net Issuance of Debt |
(379)
|
(416)
|
(537)
|
(466)
|
(595)
|
(786)
|
(950)
|
(1 096)
|
(1 147)
|
(1 144)
|
(1 163)
|
(1 194)
|
(1 227)
|
|
| Cash Paid for Dividends |
0
|
(49 959)
|
0
|
(99 878)
|
(99 878)
|
(49 919)
|
0
|
(20 411)
|
(20 411)
|
(20 411)
|
0
|
(20 272)
|
(20 272)
|
|
| Other |
(49 959)
|
50
|
0
|
49 957
|
49 967
|
(40)
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(50 338)
N/A
|
22 955
N/A
|
22 834
-1%
|
23 361
+2%
|
23 617
+1%
|
(49 901)
N/A
|
(50 065)
0%
|
(21 120)
+58%
|
(23 063)
-9%
|
(24 663)
-7%
|
(24 691)
0%
|
(24 584)
+0%
|
(25 435)
-3%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
55 564
|
20 930
|
21 845
|
(8 275)
|
(46 682)
|
1 978
|
15 477
|
19 699
|
926
|
8 862
|
(5 664)
|
(13 853)
|
4 996
|
|
| Net Change in Cash |
80 308
N/A
|
262 455
+227%
|
(349 517)
N/A
|
(531 061)
-52%
|
(486 300)
+8%
|
(533 672)
-10%
|
297 841
N/A
|
239 413
-20%
|
224 221
-6%
|
(40 054)
N/A
|
(274 199)
-585%
|
(176 449)
+36%
|
(212 936)
-21%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
239 724
N/A
|
206 616
-14%
|
190 488
-8%
|
11 615
-94%
|
(13 663)
N/A
|
(8 736)
+36%
|
18 104
N/A
|
42 864
+137%
|
32 436
-24%
|
47 435
+46%
|
34 259
-28%
|
24 972
-27%
|
20 559
-18%
|
|
Switch to:
Switch to:
See Also
Discover More
